van der Made I - Search Results

1

Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.

Matthijsen RA, de Winther MP, Kuipers D, van der Made I, Weber C, Herias MV, Gijbels MJ, Buurman WA. Matthijsen RA, et al. Among authors: van der made i. Circulation. 2009 Apr 28;119(16):2188-95. doi: 10.1161/CIRCULATIONAHA.108.830661. Epub 2009 Apr 20. Circulation. 2009. PMID: 19380618

2

Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition.

Ghesquiere SA, Gijbels MJ, Anthonsen M, van Gorp PJ, van der Made I, Johansen B, Hofker MH, de Winther MP. Ghesquiere SA, et al. Among authors: van der made i, van gorp pj. J Lipid Res. 2005 Feb;46(2):201-10. doi: 10.1194/jlr.M400253-JLR200. Epub 2004 Dec 1. J Lipid Res. 2005. PMID: 15576846 Free article.

3

P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.

Xanthoulea S, Gijbels MJ, van der Made I, Mujcic H, Thelen M, Vergouwe MN, Ambagts MH, Hofker MH, de Winther MP. Xanthoulea S, et al. Among authors: van der made i. Cardiovasc Res. 2008 Nov 1;80(2):309-18. doi: 10.1093/cvr/cvn193. Epub 2008 Jul 15. Cardiovasc Res. 2008. PMID: 18628255

4

Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation.

Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, Frederik P, van der Made I, Daugherty A, Sijbers AM, Fisher A, Long CJ, Saftig P, Black D, Daemen MJ, Cleutjens KB. Lutgens E, et al. Among authors: van der made i. Circulation. 2006 Jan 3;113(1):98-107. doi: 10.1161/CIRCULATIONAHA.105.561449. Epub 2005 Dec 19. Circulation. 2006. PMID: 16365196

5

Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype.

Kanters E, Gijbels MJ, van der Made I, Vergouwe MN, Heeringa P, Kraal G, Hofker MH, de Winther MP. Kanters E, et al. Among authors: van der made i. Blood. 2004 Feb 1;103(3):934-40. doi: 10.1182/blood-2003-05-1450. Epub 2003 Sep 25. Blood. 2004. PMID: 14512319 Free article.

6

Macrophage retinoblastoma deficiency leads to enhanced atherosclerosis development in ApoE-deficient mice.

Boesten LS, Zadelaar AS, van Nieuwkoop A, Hu L, Jonkers J, van de Water B, Gijbels MJ, van der Made I, de Winther MP, Havekes LM, van Vlijmen BJ. Boesten LS, et al. Among authors: van vlijmen bj, van nieuwkoop a, van der made i, van de water b. FASEB J. 2006 May;20(7):953-5. doi: 10.1096/fj.05-4530fje. Epub 2006 Apr 3. FASEB J. 2006. PMID: 16585057

7

Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions.

Goossens P, Gijbels MJ, Zernecke A, Eijgelaar W, Vergouwe MN, van der Made I, Vanderlocht J, Beckers L, Buurman WA, Daemen MJ, Kalinke U, Weber C, Lutgens E, de Winther MP. Goossens P, et al. Among authors: van der made i. Cell Metab. 2010 Aug 4;12(2):142-53. doi: 10.1016/j.cmet.2010.06.008. Cell Metab. 2010. PMID: 20674859 Free article.

8

Oxidised plant sterols as well as oxycholesterol increase the proportion of severe atherosclerotic lesions in female LDL receptor+/ - mice.

Plat J, Theuwissen E, Husche C, Lütjohann D, Gijbels MJ, Jeurissen M, Shiri-Sverdlov R, van der Made I, Mensink RP. Plat J, et al. Among authors: van der made i. Br J Nutr. 2014 Jan 14;111(1):64-70. doi: 10.1017/S0007114513002018. Epub 2013 Jun 18. Br J Nutr. 2014. PMID: 23773414

9

Macrophage secretory phospholipase A2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology.

Curfs DM, Ghesquiere SA, Vergouwe MN, van der Made I, Gijbels MJ, Greaves DR, Verbeek JS, Hofker MH, de Winther MP. Curfs DM, et al. Among authors: van der made i. J Biol Chem. 2008 Aug 1;283(31):21640-8. doi: 10.1074/jbc.M710584200. Epub 2008 May 28. J Biol Chem. 2008. PMID: 18511424 Free article.

10

Perfluorohexane-loaded macrophages as a novel ultrasound contrast agent: a feasibility study.

Kornmann LM, Curfs DM, Hermeling E, van der Made I, de Winther MP, Reneman RS, Reesink KD, Hoeks AP. Kornmann LM, et al. Among authors: van der made i. Mol Imaging Biol. 2008 Sep;10(5):264-70. doi: 10.1007/s11307-008-0146-3. Epub 2008 Jun 7. Mol Imaging Biol. 2008. PMID: 18536974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page